With a distinguished background in investment management and strategic operations, Regan O'Neill has established himself as a pivotal player in the financial landscape. He possesses extensive experience driving growth for emerging businesses through operational leadership and market analysis. His track record showcases an ability to identify lucrative opportunities across diverse sectors, leveraging insights from his years of hands-on involvement with startups and mature enterprises alike. As an influential figure within corporate finance, he focuses on enabling companies to optimize their performance while navigating complex market dynamics.
With a distinguished background in investment management and strategic operations, Regan O'Neill has established himself as a pivotal player in the financial landscape. He possesses extensive experience driving growth for emerging businesses through operational leadership and market analysis. His track record showcases an ability to identify lucrative opportunities across diverse sectors, leveraging insights from his years of hands-on involvement with startups and mature enterprises alike. As an influential figure within corporate finance, he focuses on enabling companies to optimize their performance while navigating complex market dynamics.
Harnessing a wealth of operational insights, Regan O'Neill approaches investment with an eye for transformational opportunities. His keen understanding of market dynamics allows him to support enterprises in enhancing their strategic positioning and accelerating growth trajectories. By prioritizing innovative solutions and collaborative partnerships, he emphasizes building resilient business models that adapt to evolving industry trends. The ability to engage deeply with diverse sectors informs his capital allocation decisions, resulting in impactful investments that seek long-term value creation.
Harnessing a wealth of operational insights, Regan O'Neill approaches investment with an eye for transformational opportunities. His keen understanding of market dynamics allows him to support enterprises in enhancing their strategic positioning and accelerating growth trajectories. By prioritizing innovative solutions and collaborative partnerships, he emphasizes building resilient business models that adapt to evolving industry trends. The ability to engage deeply with diverse sectors informs his capital allocation decisions, resulting in impactful investments that seek long-term value creation.
| Trades 501 | Longs Won 219/501 43% | Profit Factor 1.55 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $11.59M |
| Average Win $4.18M | Best Trade (Jun 29) $204.8M | Sharpe Ratio -10.34 |
| Average Loss -$2.09M | Worst Trade (Aug 25) -$134.47M | Z-Score 0.91 (63.47%) |
| Commissions $0 | Avg. Trade Length 6m 6d | Expectancy $655,259.79 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% | 0.43% | 7.6% |
| Consecutive Losing Trades | 1,205 | 1,084 | 964 | 843 | 723 | 602 | 482 | 361 | 241 | 120 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 2978 29786AAL0 | 10M | $9.46M | $9.46M | - | - | - | 0.0 |
| 3003 30034WAD8 | 15M | $19.61M | $18.31M | - | -$1.29M | -6.59% | 0.0 |
| 8425 842587ED5 | 15M | $15.17M | $15.17M | - | - | - | 0.0 |
| 9293 92939UAP1 | 20M | $23.34M | $22.65M | - | -$687,300 | -2.94% | 0.0 |
AADX Applied Aerospace & Defense, Inc. | 350,000 | $7.26M | $4.53M | - | -$2.73M | -37.63% | +3.192% |
AAPL Apple Inc. | 270,000 | $78.13M | $86.39M | - | $8.26M | 10.58% | -2.511% |
ABVX Abivax SA ADR | 24,000 | $3.2M | $2.75M | - | -$443,280 | -13.86% | +0.662% |
ACET Adicet Bio, Inc. | 62,500 | $526,250 | $599,375 | - | $73,125 | 13.9% | +1.697% |
AEP American Electric Power Company, Inc. | 500,000 | $68.41M | $62.25M | - | -$6.16M | -9% | -0.168% |
AERO Aero Grow International, Inc. | 175,000 | $3.84M | $2.75M | - | -$1.09M | -28.37% | +1.944% |
AGMB Agomab Therapeutics NV | 35,000 | $367,150 | $552,300 | - | $185,150 | 50.43% | +6.406% |
AGRO Adecoagro S.A. | 200,000 | $1.59M | $2.35M | - | $768,000 | 48.42% | +1.466% |
AHR American Healthcare REIT, Inc. | 800,000 | $41.72M | $43.78M | - | $2.06M | 4.93% | -1.865% |
AKR Acadia Realty Trust | 100,000 | $2.42M | $2.03M | - | -$387,000 | -16.02% | +0.049% |
ALH Alliance Laundry Holdings Inc. | 450,000 | $9.16M | $10.23M | - | $1.07M | 11.7% | +0.22% |
ALHC Alignment Healthcare, Inc. | 350,000 | $6.91M | $4.74M | - | -$2.17M | -31.44% | -0.037% |
ALMR Alamar Biosciences, Inc. | 100,000 | $2.71M | $3.08M | - | $371,000 | 13.7% | +0.752% |
AMBQ Ambiq Micro, Inc. | 50,000 | $4.42M | $2.87M | - | -$1.54M | -34.94% | +1.808% |
ANDG Andersen Group Inc. Class A Common Stock | 150,000 | $3.89M | $8.44M | - | $4.55M | 116.97% | -2.071% |
APGE Apogee Therapeutics Inc. | 30,000 | $2.53M | $4.05M | - | $1.53M | 60.47% | 0.0 |